GO
Loading...

Bristol-Myers Squibb Co

More

  • Final Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 6:04 PM ET

    Baxter International Inc. fell$. 18 or. 2 percent, to $76.47. Bristol-Myers Squibb Co. rose$. 41 or. 8 percent, to $49.80. Hospira rose$. 12 or. 2 percent, to $51.84.

  • Midday Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 1:31 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $76.38. Bristol-Myers Squibb Co. rose$. 02 or percent, to $49.41. Hospira rose $1.03 or 2.0 percent, to $52.75.

  • Early Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 10:33 AM ET

    Baxter International Inc. fell$. 10 or. 1 percent, to $76.55. Bristol-Myers Squibb Co. fell$. 21 or. 4 percent, to $49.18. Hospira rose $2.43 or 4.7 percent, to $54.15.

  • NEW YORK, July 28- Pfizer Inc's vulnerability to cheaper generics and its weak roster of experimental medicines will be on display Tuesday when the company reports quarterly earnings, reviving interest in its pursuit of AstraZeneca Plc or other deals to fortify its pipeline.

  • Final Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $49.46. Hospira rose $1.16 or 2.3 percent, to $51.82.

  • July 24- Bristol-Myers Squibb Co reported better-than-expected quarterly results, helped by cost controls and strong sales of its Eliquis blood clot preventer and Yervoy treatment for melanoma. Sales of Eliquis, which Bristol-Myers co-markets with Pfizer Inc, rose to $171 million.

  • Midday Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $49.52. Hospira rose$. 74 or 1.5 percent, to $51.40.

  • Early Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $49.16. Hospira rose$. 03 or. 1 percent, to $50.69.

  • NEW YORK, July 24- Major global stock markets edged higher while the euro rose from an eight-month low against the U.S. dollar on Thursday following upbeat euro zone data and stronger-than-expected U.S. earnings.

  • Bristol 2Q net drops on lower drug sales, charges Thursday, 24 Jul 2014 | 7:42 AM ET

    NEW YORK— Bristol-Myers Squibb Co.' s exit from the diabetes business, plus higher taxes and research spending, combined to slash the drugmaker's second-quarter profit by 38 percent, but the company handily beat Wall Street's muted profit expectations.

  • Final Glance: Pharmaceuticals companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 76 or 1.0 percent, to $76.87. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $49.12. Hospira rose$. 31 or. 6 percent, to $50.78.

  • Midday Glance: Pharmaceuticals companies Tuesday, 22 Jul 2014 | 1:57 PM ET

    Baxter International Inc. rose$. 93 or 1.2 percent, to $77.04. Bristol-Myers Squibb Co. rose$. 41 or. 8 percent, to $49.33. Hospira rose$. 27 or. 5 percent, to $50.74.

  • Early Glance: Pharmaceuticals companies Monday, 21 Jul 2014 | 11:37 AM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $76.15. Bristol-Myers Squibb Co. fell$. 28 or. 6 percent, to $48.84. Hospira fell$. 06 or. 1 percent, to $50.09.

  • Midday Glance: Pharmaceuticals companies Wednesday, 16 Jul 2014 | 2:54 PM ET

    Baxter International Inc. fell$. 23 or. 3 percent, to $76.53. Bristol-Myers Squibb Co. fell$. 08 or. 2 percent, to $48.63. Hospira fell$. 17 or. 3 percent, to $50.58.

  • Early Glance: Pharmaceuticals companies Wednesday, 16 Jul 2014 | 11:11 AM ET

    Baxter International Inc. fell$. 09 or. 1 percent, to $76.67. Bristol-Myers Squibb Co. rose$. 17 or. 3 percent, to $48.88. Hospira rose$. 04 or. 1 percent, to $50.79.

  • Cramer’s Bristol-Myers theorem: What is it? Monday, 7 Jul 2014 | 6:28 PM ET

    You always hear Cramer shouting about Bristol – Maaah-yerss. Why is that?

  • July 1- Bristol-Myers Squibb Co said it was voluntarily recalling six lots of the injectable version of its blood thinner, Coumadin, in the United States, after particulate matter was found in some unreleased samples.

  • Early movers: NKE, DD, PFE, GM, INTC, BMY & more Friday, 27 Jun 2014 | 7:33 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • NEW YORK, June 25- U.S. stock investors ignored weak economic data and pushed equities higher on Wednesday, as drugmakers' shares rose and a Supreme Court ruling lifted major broadcaster stocks, while German bond yields hit the year's low on safe-haven bids.

  • US STOCKS-Wall St gains with drugmakers, broadcasters Wednesday, 25 Jun 2014 | 5:09 PM ET

    *Monsanto rallies on outlook and stock-repurchase plans. *CBS shares jump after Supreme Court ruling. Shares of CBS jumped 6.2 percent to $62.48 after the U.S. Supreme Court ruled that online TV startup Aereo Inc violates copyright law by using tiny antennas to provide subscribers with broadcast network content via the Internet.